These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 9887654

  • 1. [Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome].
    Baron F, Hermanne JP, Fassotte MF, Beguin Y, Fillet G.
    Rev Med Liege; 1998 Nov; 53(11):651-3. PubMed ID: 9887654
    [Abstract] [Full Text] [Related]

  • 2. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S, Camós M, López-Guillermo A, Bosch F, Cervantes F, Blandé J, Esteve J, Cobo F, Nomdedeu B, Campo E, Montserrat E.
    Cancer; 2000 May 01; 88(9):2142-8. PubMed ID: 10813727
    [Abstract] [Full Text] [Related]

  • 3. Gonadal function following ABVD therapy for Hodgkin's disease.
    Kulkarni SS, Sastry PS, Saikia TK, Parikh PM, Gopal R, Advani SH.
    Am J Clin Oncol; 1997 Aug 01; 20(4):354-7. PubMed ID: 9256888
    [Abstract] [Full Text] [Related]

  • 4. G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease.
    Gustavsson A.
    Acta Oncol; 1997 Aug 01; 36(5):483-8. PubMed ID: 9292744
    [Abstract] [Full Text] [Related]

  • 5. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP.
    Semin Oncol; 1990 Feb 01; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [Abstract] [Full Text] [Related]

  • 6. [Hodgkin's disease with systemic vasculitis and Lambert-Eaton myasthenic syndrome--case report].
    Homenda W, Hellmann A.
    Wiad Lek; 2000 Feb 01; 53(9-10):574-8. PubMed ID: 11148928
    [Abstract] [Full Text] [Related]

  • 7. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS.
    J Clin Oncol; 1998 Mar 01; 16(3):1235. PubMed ID: 9508214
    [No Abstract] [Full Text] [Related]

  • 8. An unusual case of spontaneous remission of Hodgkin's disease after a single cycle of COPP-ABV chemotherapy followed by infectious complications.
    Bang SM, Cheong JW, Yang WI, Hahn JS.
    Yonsei Med J; 2005 Jun 30; 46(3):425-30. PubMed ID: 15988816
    [Abstract] [Full Text] [Related]

  • 9. The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease.
    Delmez JA, Safdar SH, Kissane JM.
    Am J Kidney Dis; 1994 May 30; 23(5):743-6. PubMed ID: 8172220
    [Abstract] [Full Text] [Related]

  • 10. Gemcitabine is active in relapsed Hodgkin's disease.
    Lucas JB, Horwitz SM, Horning SJ, Sayegh A.
    J Clin Oncol; 1999 Aug 30; 17(8):2627-8. PubMed ID: 10561333
    [No Abstract] [Full Text] [Related]

  • 11. MOPP, ABVD, or both to treat Hodgkin's disease.
    Martino R, Nomdedeu J, Brunet S.
    N Engl J Med; 1993 Apr 08; 328(14):1045; author reply 1045-6. PubMed ID: 7680766
    [No Abstract] [Full Text] [Related]

  • 12. Alternating drug combinations for advanced Hodgkin's disease.
    N Engl J Med; 1982 Sep 09; 307(11):687-9. PubMed ID: 6180317
    [No Abstract] [Full Text] [Related]

  • 13. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    Fermé C, Eghbali H, Meerwaldt JH, Rieux C, Bosq J, Berger F, Girinsky T, Brice P, van't Veer MB, Walewski JA, Lederlin P, Tirelli U, Carde P, Van den Neste E, Gyan E, Monconduit M, Diviné M, Raemaekers JM, Salles G, Noordijk EM, Creemers GJ, Gabarre J, Hagenbeek A, Reman O, Blanc M, Thomas J, Vié B, Kluin-Nelemans JC, Viseu F, Baars JW, Poortmans P, Lugtenburg PJ, Carrie C, Jaubert J, Henry-Amar M, EORTC-GELA H8 Trial.
    N Engl J Med; 2007 Nov 08; 357(19):1916-27. PubMed ID: 17989384
    [Abstract] [Full Text] [Related]

  • 14. [Four cases of Hodgkin's disease treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride].
    Kozai Y, Ohyama T, Kodo H, Tomori G.
    Gan To Kagaku Ryoho; 1992 Dec 08; 19(14):2407-9. PubMed ID: 1281397
    [Abstract] [Full Text] [Related]

  • 15. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
    Canellos GP.
    Leukemia; 1996 Jun 08; 10 Suppl 2():s68. PubMed ID: 8649055
    [No Abstract] [Full Text] [Related]

  • 16. Simultaneously occurring alopecia areata and Hodgkin's lymphoma: complete remission of both diseases with MOPP/ABV chemotherapy.
    Chan PD, Berk MA, Kucuk O, Singh S.
    Med Pediatr Oncol; 1992 Jun 08; 20(4):345-8. PubMed ID: 1376855
    [Abstract] [Full Text] [Related]

  • 17. [Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?].
    Schoeffler A, Levy E, Weinborn M, Cuny JF, Schmutz JL, Barbaud A, Cribier B, Bursztejn AC.
    Ann Dermatol Venereol; 2014 Feb 08; 141(2):134-40. PubMed ID: 24507208
    [Abstract] [Full Text] [Related]

  • 18. More than MOPP for advanced Hodgkin's disease?
    Mayer RJ.
    N Engl J Med; 1982 Apr 01; 306(13):800-2. PubMed ID: 6174866
    [No Abstract] [Full Text] [Related]

  • 19. MOPP, ABVD, or both to treat Hodgkin's disease.
    Aisenberg AC.
    N Engl J Med; 1993 Apr 08; 328(14):1045; author reply 1045-6. PubMed ID: 7680765
    [No Abstract] [Full Text] [Related]

  • 20. The cure of Hodgkin's disease with drugs.
    DeVita VT, Hubbard SM, Moxley JH.
    Adv Intern Med; 1983 Apr 08; 28():277-302. PubMed ID: 6188346
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.